Leandro Mieravilla

Develop market research for commercial agreements among pharma companies.
Obtain successful trade agreements at pharmaceutical market.
Evaluation and development of potential markets.
Analyze specific markets and products to be incorporated at companies’ portfolio.
Increase sales: $ 300 K in 2008 and $ 400 K during first period worked during 2005.

Managed affiliates´ global business. In charged of sales force coaching, commercial, administration, operations, human and legal resources departments.
Developed logistic solutions for new markets to bio-pharmaceutical and medical products as well as courier, warehousing and shipping/distribution.
Implemented new strategies orientated to facilitate services for clinical development, distribution
of biological products worldwide and clinical samples recollection.
Created new strategic alliances with Airlines for domestic and international services.
Sales increased: 2006, $ 960 K, 2007, $ 1.2 million and 2008, $ 800 K (6 months).
People in charge: 60 in order to grow our services in quantity & quality.

Developed new markets at Central America and Caribbean regions (Guatemala, Belize, Honduras, Nicaragua, Dominic Republic, Cuba, Mexico and Panama) evaluating global opportunities.
Increased regional sales in $ 950 K 2004 vs. 2003.
Created new promotional activities to enhance products performance adapted to different markets.
Implemented key marketing activities (e.g. brand tracking, forecasting programs), regional pricing strategy, monitoring brand budgets, forecasts and expenses.
People in charge 40. Supervised & coached region affiliates´ teams.

Achieved successful launches of new biotechnology products in several markets (Japan, Australia, India, Malaysia, Pakistan, Hong Kong, Germany, Brazil, Chile, Colombia, Venezuela and Mexico) at Rheumatology/Dermatology & Hemophilia businesses, organizing international product managers teams. Expertise in Rheumatology, Hemophilia and Dermatology.
Obtained “Excellence in Intercontinental – Wyeth, year 2000” award for Enbrel and Benefix outstanding performance worldwide working at Global Brand Teams.
Collaborated to achieved Enbrel (Rheumatology/Dermatology) record sales worldwide of $ 650 million / annual operating budget $ 65 million, in 2000. In Argentina, sales reached $ 3.6 million with only 6,654 units in 2001 (260 % above 2000) / Annual operating budget $ 350 K and Benefix (Hemophilia) record sales worldwide of $ 190 million / Annual operating budget $ 20 million, in 2000. In Argentina, sales reached $ 1.2 million / Annual operating budget $ 100 K.
Contributed to the writing/input of global launch, product positioning, pricing strategy, marketing plans, identifying trends, opportunities and threats (worldwide and in each key local market).
Designed and implemented marketing plans to accelerate the introduction of new recombinant products (Enbrel for Rheumatoid Arthritis/Dermatology and Benefix for Hemophilia B from Genetics Institute), being member at Global Brand Teams.
Developed patients and patient associations’ educational programs, support and follow up.
People in charge 10, located at different regions

Successfully launched Tiadyl (Candesartan), $ 1.8 million sales in 1997 for Cardiology and Norvir (first Protease Inhibitor) $ 2.5 million sales in 1996 for Infectology, obtaining the ”Abbott International Award 1997” for Norvir´s (HIV product) Sales reached US$ 1.7 million / Annual operating budget $ 100 K.
Expertise in Onco-Urology, Cardiology and Infectology (HIV).
Built relationships with key opinion leaders and advisory boards. Supervised & coordinated regional sales force teams.
People in charge: 5, members of special sales force team.